Wed, Nov 11 02:44 AM

Hims & Hers to offer unapproved peptides after US eases curbs

Investing.com•Tue, Nov 10, 2026, 07:48 AM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/stock-market-news/hims--hers-narrows-2026-revenue-forecast-as-margins-contract-5013239)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #hims #hers #offer #unapproved #peptides #eases #curbs

More Headlines

FinanceSeeking Alpha• 14m ago

QT Imaging Holdings, Inc. (QTI) Q3 2026 Earnings Call Transcript

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 19m ago

Webtoon Entertainment's Big Bets Are The Only Thing Stopping A Downgrade

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 24m ago

Sonos, Inc. (SONO) Q4 2026 Earnings Call Transcript

Developing story — details emerging. Check the source link for the latest updates.

FinanceBloomberg Markets• 27m ago

Hedge Fund Risk Retreat Largest in a Decade, Morgan Stanley Says

Global equity hedge funds cut risk at the steepest rate in more than a decade through the first week of November as a widespread unwind gathered steam, Morgan Stanley prime brokers wrote in a note dated Tuesday.

FinanceInvesting.com• 28m ago

Airbnb CSO Nathan Blecharczyk sells $21.9 million in stock

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 28m ago

Landmark Bancorp director Alexander sells $6,630 in shares

Developing story — details emerging. Check the source link for the latest updates.